Singapore markets open in 7 hours 54 minutes
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,039.16 +20.77 (+0.41%) Dow
38,058.25 +154.96 (+0.41%) Nasdaq
15,738.33 +132.85 (+0.85%) Bitcoin USD
59,017.29 +1,992.56 (+3.49%) CMC Crypto 200
1,272.11 +1.36 (+0.11%)
GSK Jan 2025 32.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:07PM EDT. Market open.
| Previous close | 0.3400 |
| Open | 0.3400 |
| Bid | 0.2500 |
| Ask | 0.4000 |
| Strike | 32.00 |
| Expiry date | 2025-01-17 |
| Day's range | 0.3400 - 0.3400 |
| Contract range | N/A |
| Volume | |
| Open interest | 780 |
Simply Wall St.GSK First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
GSK ( LON:GSK ) First Quarter 2024 Results Key Financial Results Revenue: UK£7.36b (up 5.9% from 1Q 2023). Net income...
BenzingaGSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Wednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling Pounds), up 10% Y/Y and 13% excluding COVID. Vaccines’ sales increased 16% at constant currency to 2.28 billion Pounds, reflecting U.S. demand for Arexvy and strong market growth for Shingrix in International and European markets. Shingrix sales reached 945 million Pounds, up 18% at constant currency, with Arexvy sales of 182 million Pounds. Specialty Medicine sales increased 17% to 2.5 billion poun
PA Media: MoneyGSK raises profit guidance as vaccine demand grows
Emma Walmsley, chief executive officer of the pharmaceutical firm hailed a ‘strong start to 2024’.
© 2024 Yahoo. All rights reserved.